Location History:
- Cambridge, GB (1999)
- Sawston, GB (1999 - 2000)
- Cambridgeshire, GB (2010)
Company Filing History:
5 out of 58 
1 out of 9 
1 out of 832,812 Years Active: 1999-2010
Title: The Innovative Mind of Phillip Thomas Hawkins
Introduction: Phillip Thomas Hawkins is a notable inventor based in Sawston, Great Britain, renowned for his impactful contributions to the field of biotechnology. With a remarkable portfolio of five patents, his work primarily focuses on the mechanisms of cellular signaling and immune responses.
Latest Patents: Among his latest patents is the groundbreaking invention of the G-beta-gamma regulated phosphatidylinositol-3' kinase. This invention revolves around the discovery and characterization of nucleotides that encode a heterodimeric enzyme responsible for producing the intracellular messenger phosphatidylinositol (3,4,5)-triphosphate upon activation by trimeric G protein-linked receptors. The enzyme consists of a catalytic subunit, p120, and a regulatory subunit, p101, both of which play crucial roles in immune system responses that can lead to inflammation. The presence of the p101 subunit significantly enhances the kinase activity when engaged with activated G proteins. This patent encompasses various applications, including p101 and p120 nucleotides, host cell expression systems, proteins, fusion proteins, polypeptides, antibodies, transgenic animals expressing p101 or p120 transgenes, and compounds that can modulate the expression or activity of these proteins for diagnostic and therapeutic purposes in inflammatory disorders.
Career Highlights: Throughout his career, Phillip has been associated with prominent institutions such as Onyx Pharmaceuticals, Inc. and The Babraham Institute. His work at these esteemed organizations has significantly advanced understanding in the fields of cellular signaling and immunology.
Collaborations: Phillip Thomas Hawkins has collaborated with distinguished individuals in his field, including Len Stephens and Sylvia Braselmann. Their partnership has fostered an environment of innovation, leading to the development of groundbreaking therapeutic solutions.
Conclusion: Phillip Thomas Hawkins stands out as a prominent inventor whose work has meaningful implications in biotechnology. His contributions through patents not only enhance scientific understanding but also pave the way for potential treatments of various inflammatory disorders. His legacy continues to inspire future innovations in the fields of science and medicine.